Semin Hear 2011; 32(4): 308-320
DOI: 10.1055/s-0031-1291935
© Thieme Medical Publishers

Audiological Management of Cogan's Syndrome

Katherine H. Teece1 , 2 , Amy P. Olund1 , 2
  • 1Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota
  • 2Division of Audiology, Mayo Clinic, Rochester, Minnesota
Further Information

Publication History

Publication Date:
24 October 2011 (online)

ABSTRACT

Cogan's syndrome (CS) is a rare immune-mediated disorder resulting in sensorineural hearing loss, ocular symptoms, and other systemic symptoms. This article prepares the audiologist to evaluate and treat the hearing loss seen in patients with CS. Previously published research in the medical literature is reviewed. Results of a retrospective chart review are presented along with four representative case studies. These serve to illustrate the variability of audiometric configurations and treatment options, which include corticosteroids, hearing aids, and cochlear implants. Audiologists play a pivotal role in the patient's medical team, which may include neuro-otologists, ophthalmologists, internists, rheumatologists, and other professionals as needed. It is especially important for audiologists to recognize the signs of CS and make prompt recommendations for medical intervention.

REFERENCES

  • 1 Cogan D G. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms.  Arch Ophthalmol. 1945;  33 144-149
  • 2 Mazlumzadeh M, Matteson E L. Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune disease.  Rheum Dis Clin North Am. 2007;  33 855-874 vii-viii
  • 3 Gluth M B, Baratz K H, Matteson E L, Driscoll C LW. Cogan syndrome: a retrospective review of 60 patients throughout a half century.  Mayo Clin Proc. 2006;  81 483-488
  • 4 McDonald T J, Vollertsen R S, Younge B R. Cogan's syndrome: audiovestibular involvement and prognosis in 18 patients.  Laryngoscope. 1985;  95 650-654
  • 5 Vollertsen R S, McDonald T J, Younge B R, Banks P M, Stanson A W, Ilstrup D M. Cogan's syndrome: 18 cases and a review of the literature.  Mayo Clin Proc. 1986;  61 344-361
  • 6 Haynes B F, Kaiser-Kupfer M I, Mason P, Fauci A S. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature.  Medicine (Baltimore). 1980;  59 426-441
  • 7 Grasland A, Pouchot J, Hachulla E, Blétry O, Papo T, Vinceneux P. Study Group for Cogan's Syndrome . Typical and atypical Cogan's syndrome: 32 cases and review of the literature.  Rheumatology (Oxford). 2004;  43 1007-1015
  • 8 Hautefort C, Loundon N, Montchilova M, Marlin S, Garabedian E N, Ulinski T. Mycophenolate mofetil as a treatment of steroid dependent Cogan's syndrome in childhood.  Int J Pediatr Otorhinolaryngol. 2009;  73 1477-1479
  • 9 Pysden K S, Long V, Ferrie C D. Leeds Teaching Hospitals NHS Trust . Cogan's syndrome: a rare cause of meningoencephalitis.  J Child Neurol. 2009;  24 753-757
  • 10 Migliori G, Battisti E, Pari M, Vitelli N, Cingolani C. A shifty diagnosis: Cogan's syndrome. A case report and review of the literature.  Acta Otorhinolaryngol Ital. 2009;  29 108-113
  • 11 Murphy G, Sullivan M O, Shanahan F, Harney S, Molloy M. Cogan's syndrome: present and future directions.  Rheumatol Int. 2009;  29 1117-1121
  • 12 Im G J, Jung H H. Side selection for cochlear implantation in a case of Cogan's syndrome.  J Laryngol Otol. 2008;  122 310-313
  • 13 Vishwakarma R, Shawn T J. Cochlear implant in Cogan's syndrome.  Eur Arch Otorhinolaryngol. 2007;  264 1121-1124
  • 14 Pasanisi E, Vincenti V, Bacciu A et al.. Cochlear implantation and Cogan syndrome.  Otol Neurotol. 2003;  24 601-604
  • 15 Lunardi C, Bason C, Leandri M et al.. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome.  [abstract] Lancet. 2002;  360 915-921
  • 16 Fugate J E, Smith J H, Claassen D O. Bilateral cochlear enhancement in Cogan syndrome.  Neurology. 2009;  73 75
  • 17 McCallum R M, Allen N B, Cobo L M et al.. Cogan's syndrome: clinical features and outcomes.  [abstract] Arthritis Rheum. 1992;  35 (Suppl) S51
  • 18 Wang R C, Parisier S C, Weiss M H, Chute P M, Hellman S A, Sauris E. Cochlear implant flap complications.  Ann Otol Rhinol Laryngol. 1990;  99 (10 Pt 1) 791-795
  • 19 Haynes B F, Pikus A, Kaiser-Kupfer M, Fauci A S. Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids.  Arthritis Rheum. 1981;  24 501-503
  • 20 Matteson E L, Tirzaman O, Facer G W et al.. Use of methotrexate for autoimmune hearing loss.  Ann Otol Rhinol Laryngol. 2000;  109 (8 Pt 1) 710-714
  • 21 Matteson E L, Fabry D A, Facer G W et al.. Open trial of methotrexate as treatment for autoimmune hearing loss.  Arthritis Rheum. 2001;  45 146-150
  • 22 Sheikh S I, Nijhawan A, Basgoz N, Venna N. Reversible Cogan's syndrome in a patient with human immunodeficiency virus (HIV) infection.  J Clin Neurosci. 2009;  16 154-156
  • 23 Sargent E W, Herrmann B, Hollenbeak C S, Bankaitis A E. The minimum speech test battery in profound unilateral hearing loss.  Otol Neurotol. 2001;  22 480-486
  • 24 Ying Y L, Hirsch B E. Atypical Cogan's syndrome: a case report.  Am J Otolaryngol. 2010;  31 279-282
  • 25 Son H J, Ulualp S O. Course of auditory impairment in Cogan's syndrome.  Am J Otolaryngol. 2009;  30 65-68
  • 26 Dillon H. Hearing Aids. New York, NY: Thieme; 2001
  • 27 Pickett J M, McFarland W. Auditory implants and tactile aids for the profoundly deaf.  [abstract] J Speech Hear Res. 1985;  28 134-150
  • 28 Cote D N, Molony T B, Waxman J, Parsa D. Cogan's syndrome manifesting as sudden bilateral deafness: diagnosis and management.  South Med J. 1993;  86 1056-1060
  • 29 Peterson G E, Lehiste I. Revised CNC lists for auditory tests.  J Speech Hear Disord. 1962;  27 62-70
  • 30 Spahr A J, Dorman M F. Effects of minimum stimulation settings for the Med El Tempo + speech processor on speech understanding.  Ear Hear. 2005;  26 (4 Suppl) 2S-6S
  • 31 Bench J, Kowal A, Bamford J. The BKB (Bamford-Kowal-Bench) sentence lists for partially-hearing children.  Br J Audiol. 1979;  13 108-112

Katherine H TeeceAu.D. 

Division of Audiology, Department of Otorhinolaryngology

Mayo Clinic, 200 First Street SW, Gonda 12-400, Rochester, MN 55905

Email: teece.katherine@mayo.edu

    >